Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01842529 · ClinicalTrials.gov registry record · Phase 2
Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery
A Phase 2 study, sponsored by Meshalkin Research Institute of Pathology of Circulation.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT01842529 is a Phase 2 study that has completed, run by Meshalkin Research Institute of Pathology of Circulation. The registered enrollment target is 60 participants.
The verdict
NCT01842529, a Phase 2 study, has completed, sponsored by Meshalkin Research Institute of Pathology of Circulation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The aim of this prospective randomized double-blind study was to compare the efficacy and safety of Botulinum toxin injection in epicardial fat pads for preventing recurrences (in early postoperative period) of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation undergoing coronary artery bypass graft (CABG) surgery.
Interventions
- BIOLOGICAL botulinum toxin injection
- BIOLOGICAL 0.9% normal saline injection
- DEVICE Implantable loop recorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01842529
The ClinicalTrials.gov registry entry for NCT01842529 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meshalkin Research Institute of Pathology of Circulation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which botulinum toxin injection is the first listed.
NCT01842529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01842529 about?
NCT01842529 is a clinical study titled "Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery". The aim of this prospective randomized double-blind study was to compare the efficacy and safety of Botulinum toxin injection in epicardial fat pads for preventing recurrences (in early postoperative period) of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation undergoing coronar...
What is the current status of trial NCT01842529?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2012-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01842529?
The interventions under investigation include: botulinum toxin injection (BIOLOGICAL), 0.9% normal saline injection (BIOLOGICAL), Implantable loop recorder (DEVICE).
Who is sponsoring clinical trial NCT01842529?
This trial is sponsored by Meshalkin Research Institute of Pathology of Circulation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.